Danaher Q2 2021 Earnings Report
Key Takeaways
Danaher Corporation announced strong second quarter 2021 results, with a 36.5% increase in revenues to $7.2 billion and net earnings of $1.7 billion, or $2.28 per diluted common share, representing an 84.0% year-over-year increase. Non-GAAP adjusted diluted net earnings per common share were $2.46, a 71.0% increase over the comparable 2020 period. The company anticipates non-GAAP core revenue growth in the mid- to high-teens percent range for the third quarter and approximately 20% for the full year 2021.
Revenues increased 36.5% year-over-year to $7.2 billion.
Net earnings were $1.7 billion, or $2.28 per diluted common share, an 84.0% year-over-year increase.
Non-GAAP adjusted diluted net earnings per common share were $2.46, a 71.0% increase over the comparable 2020 period.
Operating cash flow was $2.1 billion, a 46.5% increase year-over-year, and non-GAAP free cash flow was $1.8 billion, a 41.0% increase year-over-year.
Danaher
Danaher
Forward Guidance
The Company anticipates that non-GAAP core revenue growth will be in the mid- to high-teens percent range for the third quarter 2021. For the full year 2021, the Company now anticipates that the non-GAAP core revenue growth rate including Cytiva will be approximately 20%.